Demonstration of Changes in Plasma Cell Subsets in Multiple Myeloma
Overview
Affiliations
Increases in free light chain (FLC) production are associated with disease progression in multiple myeloma (MM). Using a double immunofluorescence staining method to produce a differential count of plasma cells in bone marrow, single populations were demonstrated, containing intact monoclonal immunoglobulins (M-Igs) in 74% and FLCs only in 8% of cases. However, 18% contained a mixture of both cell populations. Progression from cells making intact M-Ig to cells restricted to FLC only production occurred in individual cases during the course of their disease. The presence of FLC only cells was associated with shortened survival.
Ohlstrom D, Walker Z, Pandey A, Davis L, Engel K, Pan Z Cancer Res Commun. 2024; 5(1):106-118.
PMID: 39699274 PMC: 11737298. DOI: 10.1158/2767-9764.CRC-24-0170.
Lu M, Chu B, Wang Y, Shi L, Gao S, Fang L Cancer Pathog Ther. 2024; 1(2):149-153.
PMID: 38328401 PMC: 10846323. DOI: 10.1016/j.cpt.2022.11.002.
Tacchetti P, Rocchi S, Zamagni E, Barbato S, Rizzello I, De Cicco G Am J Hematol. 2022; 97(12):1607-1615.
PMID: 36198076 PMC: 9828555. DOI: 10.1002/ajh.26747.
Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma.
Ovejero S, Moreaux J Explor Target Antitumor Ther. 2022; 2(1):65-106.
PMID: 36046090 PMC: 9400753. DOI: 10.37349/etat.2021.00034.
Kraj M, Kruk B, Endean K, Warzocha K, Budziszewska K, Dabrowska M Case Rep Hematol. 2016; 2015:809840.
PMID: 26881153 PMC: 4736005. DOI: 10.1155/2015/809840.